Chinese Mainland-Traded Hengrui Pharma Files for Hong Kong Listing to Fund R&D Projects
Published on January 8, 2025
a generic drug manufacturer, Hengrui Pharma has significantly increased its investment in innovative drugs. It has established a specialized